Skip to main content
Premium Trial:

Request an Annual Quote

BioTime Subsidiary Inks Stem Cell Distribution Deal

NEW YORK (GenomeWeb News) – BioTime said yesterday that its Embryome Sciences subsidiary has inked a manufacturing and distribution deal with Lifeline Cell Technology, a subsidiary of International Stem Cell.
 
The partners intend to manufacture cell lines and supplies that scientists will use in stem cell research for regenerative medicine and drug discovery. They said the progenitor cell lines will be produced and distributed jointly using Emryome Sciences’ Embryonics technology, International Stem Cell’s parthenogenetic stem cell lines derived from unfertilized human eggs, and technology and approved hES cell lines licensed from the Wisconsin Alumni Research Foundation.
 
Data from the cell lines will be presented on Embryome Sciences’ future Embryome.com online database, Alameda, Calif.-based BioTime said. International Stem Cell also will contribute manufacturing and quality-control expertise.
 
Financial terms of the alliance were not disclosed.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.